|
TUBGCP4 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.140830E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.101700E-03 |
| Normal-vs-Stage2 |
4.250200E-02 |
| Normal-vs-Stage3 |
2.434100E-04 |
| Normal-vs-Stage4 |
4.822400E-03 |
| Stage1-vs-Stage2 |
9.342600E-01 |
| Stage1-vs-Stage3 |
1.619580E-01 |
| Stage1-vs-Stage4 |
5.049400E-01 |
| Stage2-vs-Stage3 |
3.040000E-01 |
| Stage2-vs-Stage4 |
5.644800E-01 |
| Stage3-vs-Stage4 |
7.103400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.594800E-04 |
| Normal-vs-AfricanAmerican |
7.408600E-01 |
| Normal-vs-Asian |
3.978000E-02 |
| Caucasian-vs-AfricanAmerican |
3.584400E-02 |
| Caucasian-vs-Asian |
4.982000E-01 |
| AfricanAmerican-vs-Asian |
1.934810E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.244510E-03 |
| Normal-vs-Female |
2.323700E-03 |
| Male-vs-Female |
4.895800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.689730E-02 |
| Normal-vs-Age(41-60Yrs) |
7.019800E-04 |
| Normal-vs-Age(61-80Yrs) |
5.198100E-03 |
| Normal-vs-Age(81-100Yrs) |
4.717400E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.248600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.389600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.740400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.525000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.739750E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.657600E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.054400E-02 |
| Classical-VS-Follicular |
1.315350E-01 |
| Classical-VS-Other |
1.332180E-01 |
| Classical-VS-Normal |
1.116140E-02 |
| Tall-VS-Follicular |
6.099600E-01 |
| Tall-VS-Other |
3.901400E-01 |
| Tall-VS-Normal |
1.840860E-03 |
| Follicular-VS-Other |
3.807600E-01 |
| Follicular-VS-Normal |
2.678100E-03 |
| Other-VS-Normal |
1.661770E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.836320E-03 |
| Normal-vs-N1 |
8.417400E-04 |
| N0-vs-N1 |
3.344200E-01 |
|
|
